157 related articles for article (PubMed ID: 11098334)
1. Safety and tolerability of bolus intravenous colistin in acute respiratory exacerbations in adults with cystic fibrosis.
Conway SP; Etherington C; Munday J; Goldman MH; Strong JJ; Wootton M
Ann Pharmacother; 2000 Nov; 34(11):1238-42. PubMed ID: 11098334
[TBL] [Abstract][Full Text] [Related]
2. Intravenous colistin sulphomethate in acute respiratory exacerbations in adult patients with cystic fibrosis.
Conway SP; Pond MN; Watson A; Etherington C; Robey HL; Goldman MH
Thorax; 1997 Nov; 52(11):987-93. PubMed ID: 9487348
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.
Cantón R; Cobos N; de Gracia J; Baquero F; Honorato J; Gartner S; Alvarez A; Salcedo A; Oliver A; García-Quetglas E;
Clin Microbiol Infect; 2005 Sep; 11(9):690-703. PubMed ID: 16104983
[TBL] [Abstract][Full Text] [Related]
4. Optimization of colistin dosing regimen for cystic fibrosis patients with chronic Pseudomonas aeruginosa biofilm lung infections.
Hengzhuang W; Green K; Pressler T; Skov M; Katzenstein TL; Wu X; Høiby N
Pediatr Pulmonol; 2019 May; 54(5):575-580. PubMed ID: 30803159
[TBL] [Abstract][Full Text] [Related]
5. [Inhaled colistin in cystic fibrosis].
Tamm M; Eich C; Frei R; Gilgen S; Breitenbücher A; Mordasini C
Schweiz Med Wochenschr; 2000 Sep; 130(39):1366-72. PubMed ID: 11059027
[TBL] [Abstract][Full Text] [Related]
6. Nebulized tobramycin in the treatment of adult CF pulmonary exacerbations.
Al-Aloul M; Nazareth D; Walshaw M
J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27(4):299-305. PubMed ID: 24219814
[TBL] [Abstract][Full Text] [Related]
7. Outpatient intravenous medications in the management of cystic fibrosis.
Rucker RW; Harrison GM
Pediatrics; 1974 Sep; 54(3):358-60. PubMed ID: 4213282
[No Abstract] [Full Text] [Related]
8. Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: a prospective, open-label, uncontrolled study.
Markou N; Markantonis SL; Dimitrakis E; Panidis D; Boutzouka E; Karatzas S; Rafailidis P; Apostolakos H; Baltopoulos G
Clin Ther; 2008 Jan; 30(1):143-51. PubMed ID: 18343250
[TBL] [Abstract][Full Text] [Related]
9. Inhaled colistin for the treatment of tracheobronchitis and pneumonia in critically ill children without cystic fibrosis.
Falagas ME; Sideri G; Korbila IP; Vouloumanou EK; Papadatos JH; Kafetzis DA
Pediatr Pulmonol; 2010 Nov; 45(11):1135-40. PubMed ID: 20658485
[TBL] [Abstract][Full Text] [Related]
10. A ten year review of colomycin.
Littlewood JM; Koch C; Lambert PA; Høiby N; Elborn JS; Conway SP; Dinwiddie R; Duncan-Skingle F
Respir Med; 2000 Jul; 94(7):632-40. PubMed ID: 10926333
[No Abstract] [Full Text] [Related]
11. Outpatient treatment of Pseudomonas aeruginosa bronchial colonization with long-term inhaled colistin, tobramycin, or both in adults without cystic fibrosis.
Berlana D; Llop JM; Manresa F; Jódar R
Pharmacotherapy; 2011 Feb; 31(2):146-57. PubMed ID: 21275493
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of multidrug-resistant Pseudomonas aeruginosa meningitis with intravenous and intrathecal colistin.
Schina M; Spyridi E; Daoudakis M; Mertzanos E; Korfias S
Int J Infect Dis; 2006 Mar; 10(2):178-9. PubMed ID: 16263315
[No Abstract] [Full Text] [Related]
13. A network meta-analysis of the efficacy of inhaled antibiotics for chronic Pseudomonas infections in cystic fibrosis.
Littlewood KJ; Higashi K; Jansen JP; Capkun-Niggli G; Balp MM; Doering G; Tiddens HA; Angyalosi G
J Cyst Fibros; 2012 Sep; 11(5):419-26. PubMed ID: 22717535
[TBL] [Abstract][Full Text] [Related]
14. [Usefulness of parenteral colistin in treating of lower respiratory infection due to multidrug-resistant Pseudomonas aeruginosa].
Endo R; Ishiguro N; Kikuta H
Kansenshogaku Zasshi; 2005 Dec; 79(12):945-50. PubMed ID: 16444976
[TBL] [Abstract][Full Text] [Related]
15. Lung Microbiota Changes Associated with Chronic Pseudomonas aeruginosa Lung Infection and the Impact of Intravenous Colistimethate Sodium.
Collie D; Glendinning L; Govan J; Wright S; Thornton E; Tennant P; Doherty C; McLachlan G
PLoS One; 2015; 10(11):e0142097. PubMed ID: 26544950
[TBL] [Abstract][Full Text] [Related]
16. Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: IV. colistimethate sodium.
Young DC; Zobell JT; Waters CD; Ampofo K; Stockmann C; Sherwin CM; Spigarelli MG
Pediatr Pulmonol; 2013 Jan; 48(1):1-7. PubMed ID: 22949160
[TBL] [Abstract][Full Text] [Related]
17. Tolerability and pharmacokinetic properties of ciprofloxacin dry powder for inhalation in patients with cystic fibrosis: a phase I, randomized, dose-escalation study.
Stass H; Weimann B; Nagelschmitz J; Rolinck-Werninghaus C; Staab D
Clin Ther; 2013 Oct; 35(10):1571-81. PubMed ID: 24054830
[TBL] [Abstract][Full Text] [Related]
18. Effect of aerosolized colistin on multidrug-resistant Pseudomonas aeruginosa in bronchial secretions of patients without cystic fibrosis.
Horianopoulou M; Lambropoulos S; Papafragas E; Falagas ME
J Chemother; 2005 Oct; 17(5):536-8. PubMed ID: 16323443
[TBL] [Abstract][Full Text] [Related]
19. Colistin-tobramycin combinations are superior to monotherapy concerning the killing of biofilm Pseudomonas aeruginosa.
Herrmann G; Yang L; Wu H; Song Z; Wang H; Høiby N; Ulrich M; Molin S; Riethmüller J; Döring G
J Infect Dis; 2010 Nov; 202(10):1585-92. PubMed ID: 20942647
[TBL] [Abstract][Full Text] [Related]
20. Intrathecal colistin and sterilization of resistant Pseudomonas aeruginosa shunt infection.
Quinn AL; Parada JP; Belmares J; O'Keefe JP
Ann Pharmacother; 2005 May; 39(5):949-52. PubMed ID: 15811909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
